文献速递牙周病牙体牙髓病口腔修复与种植

含二甲双胍牙科树脂通过促进人牙周膜干细胞成骨与成牙骨质分化用于牙周与牙根再生

Dental resin for periodontal and tooth root regeneration via metformin to enhance osteogenic and cementogenic differentiation of human periodontal ligament stem cells.
PubMed 文献 · J Dent · 2024-12-04

本研究开发了一种释放二甲双胍的新型牙科树脂,用于修复根面龋和牙周缺损。含7.5%二甲双胍的树脂力学性能与商用对照相当,能促进人牙周膜干细胞增殖,并显著提高碱性磷酸酶活性、矿化合成及成骨与成牙骨质分化标志物表达。

要点

  • 含7.5%二甲双胍树脂力学性能与商用对照相当,满足临床要求。
  • 二甲双胍组碱性磷酸酶活性为对照的1.8倍(p<0.05)。
  • 二甲双胍组成骨与成牙骨质分化值分别为对照的2.3倍和2.5倍(p<0.05)。

核心结论

  • 首次配制出二甲双胍树脂,可同时促进成牙骨质与成骨分化。
  • 该树脂力学强度高,支持人牙周膜干细胞黏附、生长与增殖。
  • 该树脂使矿化合成超过无二甲双胍对照的2倍,有望用于根面龋修复及牙周组织再生。

研究设计与样本

  • 体外研究:制备不同二甲双胍浓度的树脂样本,用高效液相色谱测定释放,评估细胞生长增殖、茜素红S染色、碱性磷酸酶活性及定量实时逆转录PCR。

主要发现

  • 含7.5%二甲双胍的树脂力学性能与商用对照相当,满足临床要求(均值±标准差;n=10)。
  • 人牙周膜干细胞在树脂上生长和增殖良好,14天时数量增加四倍(p>0.1)。
  • 二甲双胍组碱性磷酸酶活性为对照的1.8倍(p<0.05)。
  • 21天时二甲双胍组矿化合成显著增加。
  • 二甲双胍组成牙骨质与成骨分化值分别为无二甲双胍对照的2.5倍和2.3倍(p<0.05)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study developed a novel dental resin incorporating metformin to repair root caries and periodontitis defects. The objectives were to: (1) Develop a novel dental resin with metformin release to fulfill the clinical requirements for mechanical properties; and (2) investigate the metformin release pattern and the effects on osteogenic and cementogenic differentiation of human periodontal ligament stem cells (hPDLSCs). METHODS: Resin specimens with different concentrations of metformin were fabricated. Metformin release was measured using high-performance liquid chromatography. Cellular growth and proliferation on resin were assessed. Alizarin red S staining and an alkaline phosphatase (ALP) activity were determined. Quantitative real-time reverse transcription PCR was employed to determine osteogenic and cementogenic differentiation. RESULTS: The resin with 7.5 % metformin had mechanical properties comparable to those of a commercial control, thus satisfying the clinical requirements (mean ± SD; n = 10). hPDLSCs showed robust growth and proliferation on resin. At 14 days, the number of hPDLSCs increased by four-fold (p > 0.1). ALP activity in the metformin group was 1.8 times higher than that of control (p < 0.05). At 21 days, the metformin group showed a significant increase in mineral synthesis. Metformin group had cementogenic and osteogenic differentiation values that were 2.5 and 2.3 times higher, respectively, than control without metformin (p < 0.05). SIGNIFICANCE: A metformin-resin was formulated that greatly promoted both cementogenic and osteogenic differentiation for the first time. This resin was mechanically strong and supported hPDLSC adhesion, growth and proliferation. This resin substantially enhanced hPDLSC osteogenic and cementogenic differentiation, yielding mineral synthesis of hPDLSCs more than 2-fold that of control without metformin. This new metformin-resin shows promise for the restoration of tooth root caries and the regeneration of periodontal tissues including alveolar bone and cementum.

来源:J Dent,查看原文。版权归原作者所有。

引用

  1. Yu K, Zhu M, Dai Z, et al. Dental resin for periodontal and tooth root regeneration via metformin to enhance osteogenic and cementogenic differentiation of human periodontal ligament stem cells. J Dent. 2024. PMID: 39643264. doi:10.1016/j.jdent.2024.105507

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。